Induction of diabetes in nonhuman primates by means of temporary arterial embolization and selective arterial injection of streptozotocin.

PURPOSE To develop and assess a technique for induction of C peptide-negative diabetes in adult nonhuman primates in preparation for preclinical investigation of type 1 diabetes treatments. MATERIALS AND METHODS First, temporary embolization of the hepatic and gastric arteries was performed in 14 adult nonhuman primates (six cynomolgus, five rhesus, and three pigtail macaques). After embolization was confirmed with angiography, streptozotocin was injected at a dose of 50-70 mg/kg into the celiac artery and branches supplying the pancreas. The macaques then were given intravenous injections of arginine and glucose, and blood levels of insulin and C peptide were measured with an enzyme-linked immunosorbent assay to determine whether diabetes had been induced. RESULTS All but one of the macaques developed persistent long-term C peptide-negative diabetes after the streptozotocin injection. One macaque did not develop diabetes after the initial injection and was given a second dose of streoptozotocin, which did induce diabetes. None of the macaques showed any symptoms of hepatic or renal injury, and only one died (of gastric dilatation 5 days after the procedure). CONCLUSION Streptozotocin injection after temporary embolization of the hepatic and gastric arteries is a safe and reproducible method for inducing C peptide-negative diabetes in adult nonhuman primates in preparation for preclinical investigation of type 1 diabetes treatments.

[1]  B. Hansen,et al.  Glucose disappearance rate in rhesus monkeys: Some technical considerations , 1988, American journal of primatology.

[2]  G. Kootstra,et al.  Diabetes induction and pancreatic transplantation in the cynomolgus monkey: methodological considerations , 1991, Transplant international : official journal of the European Society for Organ Transplantation.

[3]  H. Toyoda,et al.  The efficacy of continuous local arterial infusion of 5-fluorouracil and cisplatin through an implanted reservoir for severe advanced hepatocellular carcinoma. , 1995, Oncology.

[4]  M. Stegall,et al.  Pancreatic islet transplantation in cynomolgus monkeys. Initial studies and evidence that cyclosporine impairs glucose tolerance in normal monkeys. , 1989, Transplantation.

[5]  P. Lacy,et al.  Transplantation of islets of Langerhans in diabetic rhesus monkeys. , 1975, Surgery.

[6]  R. Hye,et al.  Animal models of diabetes mellitus: physiology and pathology. , 1983, The Journal of surgical research.

[7]  L. Jansson.  The regulation of pancreatic islet blood flow. , 1994, Diabetes/metabolism reviews.

[8]  H. Auchincloss,et al.  Transplantation of pancreatic islets in diabetic nonhuman primates. , 1994, Transplantation proceedings.

[9]  R. Bergman,et al.  Repeatability of Insulin Sensitivity and Glucose Effectiveness From the Minimal Model: Implications for Study Design , 1994, Diabetes.

[10]  F. Thomas,et al.  The preclinical model of choice. , 2002, Transplantation.

[11]  C. Howard.  Nonhuman Primates as Models for the Study of Human Diabetes Mellitus , 1982, Diabetes.

[12]  J F Elliott,et al.  Clinical outcomes and insulin secretion after islet transplantation with the Edmonton protocol. , 2001, Diabetes.

[13]  D. Harlan,et al.  CTLA4-Ig and anti-CD40 ligand prevent renal allograft rejection in primates. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[14]  C. Ricordi,et al.  Islet Cell Transplantation: In Vivo and in Vitro Functional Assessment of Nonhuman Primate Pancreatic Islets , 2000, Cell transplantation.

[15]  D. Kendall,et al.  Successful islet autotransplantation in humans: functional insulin secretory reserve as an estimate of surviving islet cell mass. , 1998, Diabetes.

[16]  A. Kirk.  Transplantation tolerance: a look at the nonhuman primate literature in the light of modern tolerance theories. , 1999, Critical reviews in immunology.

[17]  W. Cefalu,et al.  Streptozotocin-induced diabetes mellitus in cynomolgus monkeys: changes in carbohydrate metabolism, skin glycation, and pancreatic islets. , 1998, Laboratory animal science.

[18]  G. Szot,et al.  Induction, maintenance, and reversal of streptozotocin-induced insulin-dependent diabetes mellitus in the juvenile cynomolgus monkey (Macaca fascilularis). , 1999, Transplantation.

[19]  J. Contreras,et al.  Successful reversal of streptozotocin-induced diabetes with stable allogeneic islet function in a preclinical model of type 1 diabetes. , 2001, Diabetes.

[20]  D. Harlan,et al.  Long-term survival and function of intrahepatic islet allografts in rhesus monkeys treated with humanized anti-CD154. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[21]  C. Ricordi,et al.  Human Islet Transplantation: Update , 2001, World Journal of Surgery.

[22]  D. Harlan,et al.  Long-term survival and function of intrahepatic islet allografts in baboons treated with humanized anti-CD154. , 1999, Diabetes.

[23]  W. Cefalu,et al.  Chronic hyperglycemia increases arterial low-density lipoprotein metabolism and atherosclerosis in cynomolgus monkeys. , 1998, Metabolism: clinical and experimental.

[24]  J. Mordes,et al.  Animal models of diabetes. , 1981, American Journal of Medicine.

[25]  K. Tsutsumi,et al.  Streptozotocin-induced diabetic cynomolgus monkey is a model of hypertriglyceridemia with low high-density lipoprotein cholesterol. , 1998, Biological & pharmaceutical bulletin.

[26]  E. Ryan,et al.  Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. , 2000, The New England journal of medicine.

[27]  G. Hoganson,et al.  Streptozotocin Diabetes in the Monkey: Plasma Levels of Glucose, Insulin, Glucagon, and Somatostatin, with Corresponding Morphometric Analysis of Islet Endocrine Cells , 1980, Diabetes.

[28]  D. Gray.  Islet isolation and transplantation techniques in the primate. , 1990, Surgery, gynecology & obstetrics.

[29]  L. Jansson.  Glucose Stimulation of Pancreatic Islet Blood Flow by Redistribution of the Blood Flow Within the Whole Pancreatic Gland , 1988, Pancreas.

[30]  C. Ricordi,et al.  Islet transplantation: present and future perspectives. , 1998, Diabetes/metabolism reviews.